Literature DB >> 30561155

Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma.

Grégoire B Morand1, Kristian Ikenberg2, Domenic G Vital1, Isabel Cardona3, Holger Moch2, Sandro J Stoeckli4, Gerhard F Huber1.   

Abstract

BACKGROUND: Epithelial-mesenchymal transition and cancer stem-like cells (CSC) have been linked to increased metastatic potential. We evaluated the prognostic impact of CD44, a CSC biomarker, on depth of invasion (DOI) and outcome in oral squamous cell carcinoma (OSCC).
METHODS: Using a multivariable logistic regression model, we evaluated in early OSCCs the relationship between CD44 expression at the invasive tumor front, DOI, sentinel lymph node biopsy, extension of nodal involvement, and survival. We also assessed whether CT and/or MRI could predict DOI preoperatively.
RESULTS: CD44 expression was associated with increased DOI (P = .018), worse disease-specific survival (P = .041) but not with positive sentinel lymph node biopsy (P > .05). Each millimeter increase in DOI was associated with a 31.1% higher risk for positive sentinel lymph node biopsy (95% CI: 5.8%-62.4%, P = .013) and with higher metastatic ratio (P = .015). Preoperative estimation of DOI by CT and/or MRI and histopathological DOI showed a strong correlation (P < .0001).
CONCLUSIONS: CD44 expression correlates with DOI, which predicts occult lymph node metastasis. Preoperative CT and/or MRI provides an accurate estimation of histopathological DOI. Both pieces of information gained preoperatively can help surgeons tailor their operation in regard to the surgical management of the neck.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarkers; carcinoma; cell surface; epithelial-mesenchymal transition; lymph nodes; neoplastic stem cells; oral cancer; receptor; sentinel lymph node biopsy; squamous cell

Year:  2018        PMID: 30561155     DOI: 10.1002/hed.25532

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  9 in total

1.  Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype.

Authors:  Grégoire B Morand; Martina A Broglie; Paul Schumann; Martin W Huellner; Niels J Rupp
Journal:  Front Oncol       Date:  2020-08-27       Impact factor: 6.244

Review 2.  Oral cancer: changing the aim of the biopsy in the age of precision medicine. A review.

Authors:  Roberto Bruschini; Fausto Maffini; Fausto Chiesa; Daniela Lepanto; Rita De Berardinis; Francesco Chu; Marta Tagliabue; Gioacchino Giugliano; Mohssen Ansarin
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

3.  Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suvmax) In Laryngeal and Hypopharyngeal Cancer.

Authors:  Jonas Werner; Martin W Hüllner; Niels J Rupp; Alexander M Huber; Martina A Broglie; Gerhard F Huber; Grégoire B Morand
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

4.  Value of SUVmax for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma.

Authors:  Stephanie A Stalder; Paul Schumann; Martin Lanzer; Martin W Hüllner; Niels J Rupp; Martina A Broglie; Grégoire B Morand
Journal:  Biology (Basel)       Date:  2020-02-02

5.  Significance of PET-CT for Detecting Occult Lymph Node Metastasis and Affecting Prognosis in Early-Stage Tongue Squamous Cell Carcinoma.

Authors:  Guo Zhao; Jianli Sun; Kai Ba; Yunxiang Zhang
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

Review 6.  Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review.

Authors:  Joshua Lubov; Mathilde Labbé; Krystelle Sioufi; Grégoire B Morand; Michael P Hier; Manish Khanna; Khalil Sultanem; Alex M Mlynarek
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-09-07

7.  The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma.

Authors:  Yu Zhang; Mingtao Chen; Zheqi Liu; Xu Wang; Tong Ji
Journal:  BMC Cancer       Date:  2021-11-20       Impact factor: 4.430

Review 8.  CD44: A Multifunctional Mediator of Cancer Progression.

Authors:  Malak Hassn Mesrati; Saiful Effendi Syafruddin; M Aiman Mohtar; Amir Syahir
Journal:  Biomolecules       Date:  2021-12-09

9.  Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mm.

Authors:  Koos Boeve; Mirjam F Mastik; Lorian Slagter-Menkema; Boukje A C van Dijk; Jan L N Roodenburg; Bernard F A M van der Laan; Max J H Witjes; Bert van der Vegt; Ed Schuuring
Journal:  Head Neck       Date:  2021-05-19       Impact factor: 3.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.